Panic Disorder Medication: Recommended Doses and Frequencies
For adults with panic disorder, start with an SSRI (paroxetine 20-40 mg daily or fluoxetine 20 mg daily) or a benzodiazepine (alprazolam 1-4 mg daily in divided doses or clonazepam 1-2 mg daily), with SSRIs preferred for long-term management due to superior safety profile, while benzodiazepines offer faster symptom relief but carry dependency risks. 1, 2
First-Line Pharmacotherapy
SSRIs (Preferred for Long-Term Treatment)
Paroxetine:
- Start: 10-20 mg once daily
- Target: 20-40 mg once daily
- Timing: Morning administration
- Evidence: Strongest efficacy data among SSRIs 1
Fluoxetine:
- Start: 5-10 mg once daily (especially if panic symptoms present)
- Target: 20 mg once daily
- Timing: Morning administration
- Note: Can be maintained on once-weekly dosing (10-60 mg) after initial stabilization 3, 4
Sertraline:
- Start: 25 mg once daily
- Target: 50-200 mg once daily
- Timing: Morning or evening
Benzodiazepines (Fastest Onset, Use Cautiously)
Alprazolam:
- Start: 0.25-0.5 mg three times daily
- Target: 1-4 mg daily in divided doses (typically 3-4 times daily)
- Maximum: 10 mg daily
- Evidence: Ranked highest for efficacy and tolerability; fastest symptom relief 1, 5
Clonazepam:
- Start: 0.25 mg twice daily
- Target: 1-2 mg daily (can be given once or twice daily due to longer half-life)
- Maximum: 4 mg daily
- Evidence: Minimum effective dose 1 mg daily; superior panic attack reduction 5, 1
Diazepam:
- Start: 2-5 mg twice daily
- Target: 5-20 mg daily in divided doses
- Evidence: Strong efficacy but less studied than alprazolam/clonazepam 1
Alternative Antidepressants
SNRIs
Venlafaxine:
TCAs
Imipramine:
- Start: 10-25 mg at bedtime
- Target: 100-250 mg daily
- Note: TCAs ranked highest as a class for efficacy but higher side effect burden 1, 6
Clomipramine:
- Start: 25 mg at bedtime
- Target: 100-250 mg daily
- Evidence: Strong efficacy data 1
Critical Treatment Considerations
Dosing Strategy for SSRIs
- Start low in panic disorder patients - they are particularly sensitive to initial activation/jitteriness 4
- Fluoxetine: Begin at 5 mg daily; 28% of patients cannot tolerate 20 mg initially
- Titrate slowly over 1-2 weeks to target dose
- Full response may take 4-8 weeks
Benzodiazepine Warnings
- Physical dependence develops - not suitable for patients with substance use history
- Taper very gradually when discontinuing (over weeks to months, not days) 7, 5
- One-third of alprazolam patients cannot discontinue after 8 months 7
- Consider time-limited use (weeks to months) while SSRI takes effect
Combination Therapy
Imipramine + Lorazepam approach:
- Allows lower doses of each medication
- Imipramine: 63.5 mg daily (vs. typical 125+ mg)
- Lorazepam: 2.4 mg daily
- Reduces side effects and improves compliance 6
- Taper benzodiazepine after 2-3 months once antidepressant effective
Treatment Duration
- Minimum 8-12 months of maintenance therapy after achieving remission 7, 8
- Patients completing full maintenance course have 85% vs 55% panic-free rates at follow-up 7
- Do not develop tolerance to therapeutic effects during maintenance 7
Ranking by Outcome
For rapid response (within weeks):
- Alprazolam or clonazepam (benzodiazepines)
- Paroxetine or fluoxetine (SSRIs)
For long-term remission and safety:
- Paroxetine, fluoxetine, or other SSRIs
- Venlafaxine (SNRI)
- TCAs (if others fail)
For tolerability (lowest dropout rates):
- Alprazolam
- Diazepam
- Paroxetine 1
Common Pitfalls to Avoid
- Don't start SSRIs at standard depression doses - panic patients need lower initial doses
- Don't prescribe benzodiazepines without exit strategy - plan taper timeline upfront
- Don't discontinue too early - minimum 12 months reduces relapse by 30%
- Don't taper benzodiazepines rapidly - use 7+ week taper schedules 5
- Don't ignore comorbid depression - requires higher medication doses 6